Virus zoonoses and their potential for contamination of cell cultures.
Silent virus infections of laboratory animals present a human health hazard, from direct exposure and from contamination of biological products for human use. Here we report two recent examples. In 1989, an outbreak of lymphocytic choriomeningitis virus (LCMV) infections was recognized among workers at a cancer research center after an animal caretaker developed viral meningitis. Investigation revealed that multiple tumor cell lines at the facility were infected with LCMV, as were research animals injected with these cell lines. Of 82 workers tested, eight (10%) were found to have been infected. The infected workers were more likely than other animal handlers to report handling athymic (nude) mice (p less than .0.007). The number of nude mice used in this facilty had increased five-fold in the previous year, possibly explaining the timing of the outbreak. This is the first reported LCMV outbreak since 1975, and the first to implicate nude mice as a source of human LCMV infections. In November 1989 and January 1990, infections caused by two distinct Ebola-like filoviruses were discovered in non-human primates at quarantine facilities in Virginia and Pennsylvania. Although 22 persons were considered to have high- or medium-risk exposures for Ebola infection, no Ebola-compatible illnesses occurred. One of the medium-risk persons had Ebola IgG antibodies confirmed by IFA and Western blot. Rigorous use of barrier precautions may have limited exposure and infection with these filoviruses. In February 1990, new groups of filovirus-infected monkeys were identified in Virginia and in Texas. Seroconversion occurred in four animal handlers, including one to very high titer, but again no illness was observed.(ABSTRACT TRUNCATED AT 250 WORDS)
Mahy
B W
BW
Division of Viral and Rickettsial Diseases, Centers for Disease Control, Atlanta, GA 30333.
Dykewicz
C
C
Fisher-Hoch
S
S
Ostroff
S
S
Tipple
M
M
Sanchez
A
A
D000818:Animals; D000830:Animals, Laboratory / Q000382:microbiology; D001688:Biological Products / Q000302:isolation & purification; D002478:Cells, Cultured / Q000382:microbiology*; D004196:Disease Outbreaks / Q000662:veterinary; D004340:Drug Contamination; D029043:Ebolavirus / Q000302:isolation & purification; D016563:Filoviridae / Q000302:isolation & purification; D006482:Hemorrhagic Fevers, Viral / Q000453:epidemiology / Q000635:transmission / Q000662:veterinary; D006801:Humans; D008216:Lymphocytic Choriomeningitis / Q000453:epidemiology / Q000635:transmission; D008217:Lymphocytic choriomeningitis virus / Q000302:isolation & purification; D011323:Primates / Q000382:microbiology; D014777:Virus Diseases / Q000453:epidemiology / Q000635:transmission / Q000662:veterinary; D014780:Viruses / Q000302:isolation & purification*
D001688:Biological Products